In which conditions is clonazepam contraindicated?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 18, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Clonazepam Contraindications

Clonazepam is absolutely contraindicated in patients with a history of benzodiazepine sensitivity, significant liver disease, and acute narrow-angle glaucoma 1.

Absolute Contraindications

According to FDA labeling, clonazepam must not be used in the following conditions 1:

  • Benzodiazepine hypersensitivity: Any history of allergic or sensitivity reactions to benzodiazepines
  • Significant hepatic disease: Clinical or biochemical evidence of substantial liver impairment
  • Acute narrow-angle glaucoma: This is an absolute contraindication; however, clonazepam may be used in patients with open-angle glaucoma who are receiving appropriate therapy

Critical Clinical Considerations

High-Risk Populations Requiring Extreme Caution

While not absolute contraindications, the following conditions warrant serious consideration before prescribing clonazepam, as they significantly impact morbidity and mortality:

Respiratory compromise 1:

  • Clonazepam causes respiratory depression
  • Use extreme caution in COPD, sleep apnea, or any compromised respiratory function
  • This becomes particularly dangerous when combined with opioids, which can be fatal

Severe renal impairment 1:

  • Clonazepam metabolites are renally excreted
  • Accumulation can lead to toxicity in patients with kidney dysfunction

Elderly patients 2:

  • Listed on the American Geriatrics Society Beers Criteria as potentially inappropriate
  • Higher risk of falls, cognitive impairment, delirium, and amnesia
  • Age-related changes in drug metabolism increase sensitivity over time

Important Safety Warnings

Sleep-disordered breathing 2:

  • Clonazepam can exacerbate sleep-disordered breathing
  • This is particularly problematic in patients with REM sleep behavior disorder who may have underlying neurodegenerative disease

Acute angle-closure glaucoma risk 3:

  • New users of benzodiazepines, including clonazepam, have significantly increased risk of developing acute angle-closure glaucoma
  • Risk is highest within the first 7 days of use (aOR = 3.09)
  • Monitor for visual disturbances, especially during initial prescription period

Porphyria 1:

  • Clonazepam may have porphyrogenic effects
  • Use with care in patients with this condition

References

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.